Svizzera -
italiano -
Swissmedic (Swiss Agency for Therapeutic Products)
prednison axapharm 5 mg compresse
axapharm ag - prednisonum - compresse - prednisonum 5 mg, lactosum monohydricum 77.2 mg, cellulosum microcristallinum, carmellosum natricum solo tenuti insieme corrisp. sodio max. 0,3 mg, povidonum k 30, magnesio stearas, pro compresso. - glukokortikosteroid-therapie - synthetika
Svizzera -
italiano -
Swissmedic (Swiss Agency for Therapeutic Products)
prednison axapharm 20 mg compresse
axapharm ag - prednisonum - compresse - prednisonum 20 mg, lactosum monohydricum 138 mg, cellulosum microcristallinum, carmellosum natricum solo tenuti insieme corrisp. sodio max. 0.5 mg, povidonum k 30, magnesio stearas, pro compresso. - glukokortikosteroid-therapie - synthetika
Unione Europea -
italiano -
EMA (European Medicines Agency)
abiraterone mylan
mylan ireland limited - abiraterone acetato - neoplasie prostatiche - endocrine therapy, other hormone antagonists and related agents - abiraterone mylan is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt). the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated. the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.
Unione Europea -
italiano -
EMA (European Medicines Agency)
abiraterone krka
krka, d.d., novo mesto - abiraterone acetato - neoplasie prostatiche - terapia endocrina - abiraterone krka is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt) (see section 5. 1)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. 1)the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel-based chemotherapy regimen.
Svizzera -
italiano -
Swissmedic (Swiss Agency for Therapeutic Products)
prednison stada 5 mg compresse
spirig healthcare ag - prednisonum - compresse - prednisonum 5 mg, lactosum monohydricum 77.2 mg, cellulosum microcristallinum, carmellosum natricum solo tenuti insieme corrisp. sodio max. 0,3 mg, povidonum k 30, magnesio stearas, pro compresso. - glukokortikosteroid-therapie - synthetika
Svizzera -
italiano -
Swissmedic (Swiss Agency for Therapeutic Products)
prednison stada 20 mg compresse
spirig healthcare ag - prednisonum - compresse - prednisonum 20 mg, lactosum monohydricum 138 mg, cellulosum microcristallinum, carmellosum natricum solo tenuti insieme corrisp. sodio max. 0.5 mg, povidonum k 30, magnesio stearas, pro compresso. - glukokortikosteroid-therapie - synthetika
Svizzera -
italiano -
Swissmedic (Swiss Agency for Therapeutic Products)
zytiga compresse
janssen-cilag ag - abirateronum - compresse - abirateroni acetas 250 mg corresp. abirateronum 223 mg, lactosum monohydricum corresp. lactosum 188.72 mg, cellulosum microcristallinum, carmellosum natricum conexum et natrii laurilsulfas corresp. natrium 5.38 mg, povidonum k 29-32, silica colloidalis anhydrica, magnesii stearas, pro compresso. - prostatico - synthetika
Italia -
italiano -
AIFA (Agenzia Italiana del Farmaco)
melfalan koanaa
koanaa healthcare gmbh - melfalan - melfalan
Italia -
italiano -
AIFA (Agenzia Italiana del Farmaco)
melfalan medac
medac gesellschaft fur klinische spezialpraparate mbh - melfalan - melfalan